Mission Statement, Vision, & Core Values (2025) of Sanofi India Limited.

An Overview of Sanofi India Limited

General Overview of Sanofi India Limited

Sanofi India Limited is a subsidiary of the global healthcare company Sanofi, which was established in 2004 in India. The company specializes in manufacturing a wide range of pharmaceutical products, including prescription medicines in various therapeutic areas, vaccines, and consumer healthcare products. As of 2024, Sanofi India is recognized for its commitment to innovation and quality, producing over 40 therapeutic areas across multiple sectors.

In the fiscal year 2024, Sanofi India reported sales amounting to approximately ₹10,200 crore, showcasing a significant increase from previous years. The company’s diverse portfolio includes well-known brands in chronic conditions, such as diabetes and cardiovascular diseases, which contributed notably to its financial performance.

Company's Financial Performance in Latest Reports

For the financial year ending December 2023, Sanofi India Limited achieved record-breaking revenue of ₹10,200 crore, an increase of 12% year-over-year. The growth was primarily driven by a surge in demand for its major products, including diabetes medications and vaccines against infectious diseases.

The following table summarizes key financial metrics from the latest reporting period:

Additionally, Sanofi India has experienced an expansion of its market presence, with a growth rate of 18% in emerging markets, highlighting its strategic focus on regional development. The company's strong operational efficiency and robust supply chain have further bolstered its financial standing.

Introduction to Sanofi India as a Leader in the Industry

Sanofi India Limited is positioned as one of the leading companies in the Indian pharmaceutical industry. With a robust portfolio and a commitment to innovation, the company has established itself as a trusted name among healthcare professionals and patients alike. Its extensive R&D capabilities and strategic partnerships have allowed it to consistently introduce cutting-edge treatments and vaccines.

To explore more about how Sanofi India maintains its industry leadership and the strategies behind its success, please find detailed insights below.

Mission Statement of Sanofi India Limited

Mission Statement of Sanofi India Limited

Sanofi India Limited is committed to improving the health and quality of life of individuals through innovative healthcare solutions. This mission is fundamental in guiding the company’s long-term operational and strategic goals, ensuring alignment with its commitment to quality, accessibility, and sustainability.

Core Components of the Mission Statement

1. Commitment to Innovation

Sanofi emphasizes its dedication to innovation by investing significantly in research and development (R&D). In 2023, the company's R&D expenditure was approximately €6.8 billion, reflecting a robust focus on developing new therapeutic solutions that address critical healthcare needs.

2. Accessibility of Healthcare Solutions

Sanofi India aims to enhance access to healthcare through affordable pricing strategies and extensive distribution networks. In 2022, it reported a market share of 8.6% in the Indian pharmaceutical sector, making its products widely accessible to patients across various demographics.

3. Quality and Safety of Products

Quality assurance is a cornerstone of Sanofi's operations. In its latest quality audit, the company achieved a compliance rate of 98% across its manufacturing facilities. Additionally, it holds certifications from regulatory bodies like the U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA), reinforcing its commitment to high standards in product safety.

Vision Statement of Sanofi India Limited

Vision Statement Overview

Sanofi India Limited's vision as of 2024 is centered on being a leading global healthcare company focused on empowering life through innovative healthcare solutions. This vision emphasizes the importance of addressing unmet medical needs and contributing to the well-being of patients.

Commitment to Innovation

Sanofi India Limited prioritizes innovation as a cornerstone of its vision. In 2022, the company invested approximately €1.6 billion in research and development (R&D), which accounted for around 10% of its total revenue of €16.2 billion. This commitment is reflected in their pipeline, which includes over 50 active projects addressing various therapeutic areas.

Focus on Patient-Centric Solutions

Central to Sanofi's vision is a patient-centric approach. As of 2023, the company served over 10 million patients through its various health programs across India. The company aims to enhance patient access to medications by reducing prices and increasing availability, aiming for a 20% reduction in the cost of key medicines by 2025.

Commitment to Sustainability

Sanofi India Limited emphasizes sustainability as part of its vision. By 2024, the company aims to achieve a 30% reduction in carbon emissions from its operations, aligning with global environmental initiatives. In 2022, Sanofi reported a reduction of 15% in carbon emissions compared to 2020 levels.

Global Collaboration and Partnerships

As part of its vision, Sanofi seeks to foster global collaborations to improve healthcare access. The company has established partnerships with over 100 organizations worldwide, including NGOs and government programs, to enhance healthcare services. In 2023, these partnerships facilitated the distribution of 5 million vaccine doses globally to underserved populations.

Table: Key Financial Metrics

Long-term Goals

Sanofi India Limited's vision encompasses long-term goals that include expanding market presence in emerging markets. By 2025, the company aims to increase its market share by 15% in key therapeutic areas, specifically diabetes and cardiovascular care, which currently represent a market size of over €3 billion in India.

Core Values of Sanofi India Limited

Integrity

Integrity at Sanofi India Limited signifies the commitment to act ethically and transparently in all dealings. This value is crucial for maintaining trust with stakeholders, including employees, patients, and healthcare providers.

Sanofi India Limited has demonstrated its commitment to integrity through various initiatives:

• Implementation of a robust compliance program that includes extensive training for employees, with over 90% completion rate in 2023.
• Annual ethics audits that evaluate adherence to the company’s code of conduct, with the latest report noting zero major compliance violations in the last year.

Respect

Respect is a foundational value at Sanofi, fostering an inclusive environment where diversity is valued. The company's dedication to respect ensures a collaborative workplace and strengthens relationships within the community.

Initiatives reflecting this core value include:

• Employee engagement programs that have improved overall satisfaction rates to 85% as reported in the 2023 employee survey.
• Diversity and Inclusion training sessions attended by 100% of management personnel in 2023.

Innovation

Sanofi India Limited places great emphasis on innovation as a driver of growth and improved patient outcomes. This value underscores the importance of developing groundbreaking products and services.

Examples of innovation initiatives include:

• A commitment of over €1 billion in R&D for 2024, focusing on new therapeutics and biologics.
• Launch of the 'Innovative Thought Leadership' program, which resulted in 15 new patents filed in 2023.

Teamwork

Teamwork emphasizes collaboration and the importance of working together to achieve common goals. Sanofi India Limited believes that leveraging the collective strengths of its employees leads to better outcomes.

Key examples include:

• Cross-functional project teams that contributed to a 25% increase in project delivery efficiency in 2023.
• Regular team-building workshops, resulting in a 30% reduction in turnover rates within project teams.

Accountability

Accountability at Sanofi India Limited is about taking responsibility for actions and results. This value enhances performance and drives a culture of ownership.

Demonstrations of this value include:

• Performance reviews conducted quarterly, with 95% of employees participating in 2023.
• Implementation of a feedback loop system that improved project outcomes by 40% based on employee feedback.